Tilray Brands (TLRY) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
9 Apr, 2026Executive summary
Achieved record Q3 net revenue of $206.7 million, up 11% year-over-year, driven by cannabis, distribution, and wellness growth, with BrewDog acquisition and Carlsberg partnership positioning annualized revenue at $1.2 billion.
Operating expenses decreased significantly due to the absence of prior year non-cash impairment charges and lower amortization, selling, litigation, and restructuring costs.
Adjusted EBITDA rose 19% to $10.7 million, reflecting improved operating performance and cost discipline.
Maintained strong liquidity with $265 million in cash and marketable securities and a net cash position of $3.5 million.
Diversified global platform includes leading positions in cannabis (Canada), craft brewing (U.S. and U.K.), medical cannabis, and wellness.
Financial highlights
Net revenue reached $206.7 million, up 11% year-over-year; gross profit was $55 million, up 6%; gross margin was 27%.
Cannabis net revenue grew 19% to $64.8 million; international cannabis sales up 73% year-over-year; gross margin at 40%.
Distribution net revenue increased 35% to $83 million; wellness net revenue up 16% to $16.4 million; beverage net revenue was $42.6 million, down 24% year-over-year.
Net loss was $25.2 million, a significant improvement from $793.5 million prior year, mainly due to non-cash impairments.
Adjusted net income was $2.4 million, up from an adjusted net loss of $2.9 million; adjusted cash operating income improved to $4.1 million.
Outlook and guidance
Fiscal 2026 adjusted EBITDA guidance reaffirmed at $62 million–$72 million, representing 13% to 31% growth over fiscal 2025.
Management focused on revenue growth, margin improvement, and positive cash flow, with continued investment in core brands and international expansion.
Guidance excludes stock-based compensation, impairments, litigation, restructuring, and other non-recurring items.
Expect continued momentum in international cannabis and beverage segments, with further operational efficiencies and cost savings from ongoing integration and scale.
Management monitoring Middle East hostilities for potential impacts on expenses and supply chain.
Latest events from Tilray Brands
- Record Q2 revenue, improved margins, and global expansion drive positive 2026 outlook.TLRY
Q2 20261 Apr 2026 - Acquisition creates a $500M global craft beverage platform and accelerates international growth.TLRY
M&A announcement2 Mar 2026 - Balanced growth across cannabis, beverages, and distribution, with innovation and efficiency focus.TLRY
TD Cowen 9th Annual Future of the Consumer Conference3 Feb 2026 - Record revenue and EBITDA growth, margin gains, and strong outlook for continued expansion.TLRY
Q4 20242 Feb 2026 - Q1 revenue hit $200M (+13% YoY), led by beverage growth and margin gains, with net loss improvement.TLRY
Q1 202519 Jan 2026 - Q2 revenue hit $211M (+9% YoY), with margin gains and Project 420 synergies advancing.TLRY
Q2 202510 Jan 2026 - Diversified global platform drives growth in cannabis, beverage, and wellness with strong financials.TLRY
Investor Presentation8 Jan 2026 - Record Q1 revenue and return to profitability driven by cannabis and distribution growth.TLRY
Q1 202622 Dec 2025 - Proxy covers director election, auditor ratification, pay, and board declassification proposals.TLRY
Proxy Filing2 Dec 2025